好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Plasma A[beta]1-40 and A[beta]1-42 Levels and the Risk of Alzheimer's Disease in the Cardiovascular Health Study
Aging and Dementia
(-)
104
Authors/Disclosures
Oscar L. Lopez, MD, FAAN Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen.
No disclosure on file
Pankaj D. Mehta, PhD No disclosure on file
Brent P. Goodman, MD (Dept of Neuro /Mayo Clinic) Dr. Goodman has nothing to disclose.
James T. Becker, PhD (University of Pittsburgh) No disclosure on file
Robert A. Sweet Robert A. Sweet has nothing to disclose.
No disclosure on file
Russell Tracy No disclosure on file
Steven T. DeKosky, MD, FAAN (McKnight Brain Institute) Dr. DeKosky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acumen. Dr. DeKosky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. DeKosky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cognition Therapeutics. Dr. DeKosky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail Pharamceuticls. Dr. DeKosky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaccinex, Inc. Dr. DeKosky has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Up-To-Date. Dr. DeKosky has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurotherapeutics .